Sort
51,593 grants matching “hepatitis”
Entry and replication of positive-sense, RNA viruses
$895,330Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
The role of apolipoproteins in viral entry and human disease
$895,330Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM
$894,925University Of Hawaii At Manoa · U01 · FY2000 · AI
Clinical
$894,794Rajesh T Gandhi · Harvard University · P30 · FY2011 · AI
Integrating Addiction Treatment and HIV Services into Primary Care Clinics in Ukraine
$894,523Frederick Lewis Altice · Yale University · R01 · FY2019 · DA
ESTABLISHMENT/MAINTENANCE OF BIOMEDICAL RESEARCH COLONY
$894,422University Of Louisiana At Lafayette · U42 · FY2004 · RR
Role of the innate immune defenses in viral infections
$894,309Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Novel Drugs to Treat Urinary Incontinence
$894,091Jan Chen · Glsynthesis, Inc. · R44 · FY2009 · AG
Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance use
$893,934Amy Caroline Justice · Yale University · U24 · FY2013 · AA
Clinical Validation Center for Hepatocellular Carcinoma
$893,833Amit Singal · Ut Southwestern Medical Center · U01 · FY2025 · CA
Durability of HBV DNA Suppression in Cirrhotics After Stopping Therapy
$893,765Harry Janssen · University Health Network · U01 · FY2014 · DK
A targeted analytical framework to optimize posthospitalization delirium pharmacotherapy in patients with Alzheimers disease and related dementias
$892,903Joshua K Lin · Brigham And Women'S Hospital · R01 · FY2023 · AG
Micro Analytical Immunochemistry
$892,557Heather Kalish · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2024 · EB
Gulf Longitudinal Follow-up (GuLF) Study
$892,530Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
2/6 COMpAAAS U01: Observation Study
$891,895Amy Caroline Justice · Yale University · U01 · FY2020 · AA
The role of cancer stem cells in liver cancer heterogeneity and subtypes
$891,493Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Molecular signatures for liver cancer diagnosis and treatment stratification
$891,493Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Genomic Classification of Human Liver Cancer
$890,387Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
$889,701Farhad Parhami · Max Biopharma, Inc. · R44 · FY2024 · DK
Observation Study of Persons with Chronic Hepatitis B Virus infection in North America
$889,332Harry Janssen · University Health Network · U01 · FY2016 · DK
Multiplexed Detection of Food and Waterborne Pathogens
$889,100Francis Barany · Weill Medical Coll Of Cornell Univ · U01 · FY2007 · AI
The Comparative Effectiveness and Safety of Oral Anticoagulants in Patients with Cirrhosis and Atrial Fibrillation
$889,086Tracey Simon · Brigham And Women'S Hospital · R01 · FY2023 · HL
Endothelial cell targeting of factor VIII for hemophilia A
$888,836Denise E Sabatino · Children'S Hosp Of Philadelphia · R01 · FY2025 · HL
Therapy of Pulmonary Diseases with Peptide-Oligonucleotide Conjugates and Small Molecule Enhancing Compounds
$888,678Rudolph Juliano · Initos Pharmaceuticals, Llc · R44 · FY2021 · TR
Xenobiotic Receptors in Mediating the Environmental Effects on Human Disease and Morbidity
$888,526Wen Xie · University Of Pittsburgh At Pittsburgh · R35 · FY2020 · ES